Fellow Harris Eyre calls for strategic investments in R&D and the application of brain-related technologies to harness the full potential of our minds.
The surge in brain disorders is having a notable effect on the economy. Brain Capital, which takes into account cognitive and non-cognitive brain abilities as well as brain health, is becoming increasingly essential to the world's economies. This is particularly evident in light of the progression of AI technology, which is substituting positions that require minimal skills.
The creation of a new industry of brain capital technologies could stimulate major economic activity, create jobs, and contribute to technological advances for the U.S. and its allies, write Harris Eyre, Rachel Meidl and co-authors.
What are the ethical and policy implications of embryoids — cell-based embryo models that mimic the early stages of human development — for use in research? Center for Health and Biosciences experts Ana Iltis and Kirstin R.W. Matthews summarize the concerns and questions raised in the recent literature.
Kirstin R.W. Matthews, Ana S. IltisAugust 21, 2023
This policy brief explores the dangerous potential of neuroweapons, the need for a “Neuroshield” to protect democracies from the risks of disinformation, the implications of brain-computer interfaces and other national security considerations related to brain health.
Harris A. Eyre, William Hynes, Geoffrey F. L. Ling, Jo-An Occhipinti, Rym Ayadi, Michael D. Matthews, Ryan Abbott, Patrick LoveAugust 10, 2023